PL
| Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
|---|---|---|---|---|---|---|---|
| High-dose glucocorticoids in COVID-19 patients with acute encephalopathy: clinical and imaging findings in a retrospective cohort study | Journal of neural transmission |  | 2024 | 24 | 4 | ||
| Frequency of Abnormally Low Neuropsychological Scores in Post-COVID-19 Syndrome: the Geneva COVID-COG Cohort | Archives of clinical neuropsychology | | 2023 | 323 | 148 | ||
| Brain functional connectivity alterations associated with neuropsychological performance 6–9 months following SARS‐CoV ‐2 infection | Human brain mapping | | 2023 | 135 | 27 | ||
| Acute TNFα levels predict cognitive impairment 6-9 months after COVID-19 infection | Psychoneuroendocrinology | | 2023 | 118 | 20 | ||
| Personality as a Predictor of Disability in Multiple Sclerosis | Archives of clinical neuropsychology | | 2023 | 127 | 60 | ||
| Markers of limbic system damage following SARS-CoV-2 infection | Brain communications | | 2023 | 135 | 26 | ||
| Utilité clinique des genome boards pour les maladies génétiques complexes | Revue médicale suisse |  | 2023 | 71 | 4 | ||
| Obstructive sleep apnea: a major risk factor for COVID-19 encephalopathy? | BMC neurology | | 2023 | 37 | 14 | ||
| Multicentric evaluation of a specific intrathecal anti-Treponema pallidum IgG index as a diagnostic biomarker of neurosyphilis: results from a retro-prospective case–control study | Sexually transmitted infections | | 2023 | 93 | 0 | ||
| Serum glial fibrillary acidic protein compared with neurofilament light chain as a biomarker for disease progression in multiple sclerosis | JAMA neurology | | 2023 | 76 | 0 | ||
| Paraneoplastic Autoimmune Limbic Encephalitis Associated with an Atypical Carcinoid Tumor of the Lung : A Case Report | Case reports in neurology | | 2023 | 73 | 10 | ||
| A Multicenter Longitudinal MRI Study Assessing LeMan-PV Software Accuracy in the Detection of White Matter Lesions in Multiple Sclerosis Patients | Journal of magnetic resonance imaging | | 2023 | 47 | 8 | ||
| Monocytosis in the acute phase of SARS-CoV-2 infection predicts the presence of anosognosia for cognitive deficits in the chronic phase | Brain, behavior, & immunity. Health | | 2022 | 96 | 11 | ||
| Omicron-specific cytotoxic t-cell responses after a third dose of mrna covid-19 vaccine among patients with multiple sclerosis treated with ocrelizumab | JAMA neurology | | 2022 | 161 | 85 | ||
| Long COVID neuropsychological deficits after severe, moderate or mild infection | Clinical and translational neuroscience | | 2022 | 425 | 261 | ||
| Association of Brain Atrophy With Disease Progression Independent of Relapse Activity in Patients With Relapsing Multiple Sclerosis | JAMA neurology | | 2022 | 144 | 42 | ||
| Robust T-Cell Responses in Anti-CD20 Treated Patients Following COVID-19 Vaccination: A Prospective Cohort Study | Clinical infectious diseases | | 2022 | 146 | 23 | ||
| Functional connectivity underlying cognitive and psychiatric symptoms in post-COVID-19 syndrome: is anosognosia a key determinant? | Brain communications | | 2022 | 270 | 58 | ||
| Answer to Letter to the Editor: High-resolution Black Blood Vessel Wall Imaging in COVID-19 Encephalopathy-is it Really Endotheliitis? | Clinical neuroradiology | | 2022 | 108 | 28 | ||
| The Two-Way Route between Delirium Disorder and Dementia: Insights from COVID-19 | Neurodegenerative diseases | | 2022 | 26 | 12 | ||
| CD4+c-Met+Itgα4+ T cell subset promotes murine neuroinflammation | Journal of neuroinflammation | | 2022 | 141 | 65 | ||
| Intrathecal Synthesis Index of Specific Anti-Treponema IgG: a New Tool for the Diagnosis of Neurosyphilis | Microbiology spectrum | | 2022 | 136 | 91 | ||
| Interleukin 8, a Biomarker to Differentiate Guillain-Barré Syndrome From CIDP | Neurology: Neuroimmunology & Neuroinflammation | | 2021 | 736 | 121 | ||
| Rabies vaccination and multiple sclerosis relapse: A retrospective cohort study | Multiple Sclerosis and Related Disorders | | 2021 | 217 | 86 | ||
| COVID‐19 encephalopathy: Clinical and neurobiological features | Journal of Medical Virology | | 2021 | 243 | 315 | ||
| c-Met enforces proinflammatory and migratory features of human activated CD4+ T cells | Cellular & Molecular Immunology | | 2021 | 212 | 149 | ||
| Live vaccines and immunosuppressive monoclonal antibodies: weighing up the benefit-risk assessment for natalizumab | Journal of Travel Medicine | | 2021 | 166 | 0 | ||
| C-reactive protein and white matter microstructural changes in COVID-19 patients with encephalopathy | Journal of neural transmission | | 2021 | 233 | 57 | ||
| Neuropathie des petites fibres dans les maladies autoimmunes systémiques | Revue médicale suisse | | 2021 | 683 | 1 | ||
| Does Endothelial Vulnerability in OSA Syndrome Promote COVID-19 Encephalopathy? | Chest | | 2021 | 103 | 31 | ||
| Cerebrovascular Complications and Vessel Wall Imaging in COVID-19 Encephalopathy—A Pilot Study | Clinical Neuroradiology | | 2021 | 221 | 97 | ||
| Cerebrospinal Fluid Features in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Reverse Transcription Polymerase Chain Reaction (RT-PCR) Positive Patients | Clinical infectious diseases | | 2021 | 181 | 98 | ||
| Encéphalopathie aiguë et Covid-19: hypothèses physiopathologiques | Revue médicale suisse | | 2021 | 173 | 129 | ||
| Unusual Microbleeds in Brain MRI of Covid-19 Patients | Journal of Neuroimaging | | 2020 | 780 | 384 | ||
| Risk of MS relapse after yellow fever vaccination: A self-controlled case series | Neurology: Neuroimmunology & Neuroinflammation | | 2020 | 170 | 57 | ||
| COVID-19-related encephalopathy responsive to high-dose glucocorticoids | Neurology | | 2020 | 166 | 1 | ||
| Serum neurofilament light chains in MS: Association with the Timed Up and Go | Neurology Neuroimmunology & Neuroinflammation | | 2020 | 181 | 48 | ||
| IL-8 as a potential biomarker in Guillain-Barre Syndrome | European Cytokine Network | | 2019 | 218 | 1 | ||
| Encephalitis and meningoencephalitis: chasing the culprit | Clinical Microbiology and Infection | | 2019 | 248 | 94 | ||
| Pachymeningitis with optic neuropathy associated with extrapulmonary tuberculosis and secondary antiphospholipid syndrome | Multiple Sclerosis and Related Disorders | | 2019 | 325 | 0 | ||
| AQP4 antibody-positive NMO spectrum disorder associated with Takayasu arteritis | Journal of the Neurological Sciences | | 2019 | 240 | 1 | ||
| Diagnostic tools for immune causes of encephalitis | Clinical Microbiology and Infection | | 2019 | 341 | 2 | ||
| Fulminant multifocal relapse in a fingolimod-treated multiple sclerosis patient | Multiple Sclerosis and Related Disorders | | 2019 | 370 | 2 | ||
| In-vivo gp100-specific Cytotoxic CD8+ T Cell Killing Assay | Bio-protocol | | 2018 | 223 | 104 | ||
| Syndrome de Guillain-Barré | Revue médicale suisse | | 2018 | 468 | 516 | ||
| Activation of human B cells negatively regulates TGF-β1 production | Journal of Neuroinflammation | | 2017 | 523 | 187 | ||
| Increased interleukin-27 cytokine expression in the central nervous system of multiple sclerosis patients | Journal of Neuroinflammation | | 2017 | 496 | 185 | ||
| Serum Neurofilament light: A biomarker of neuronal damage in multiple sclerosis | Annals of Neurology | | 2017 | 524 | 0 | ||
| Does fear of falling predict gait variability in multiple sclerosis? | Journal of the Neurological Sciences | | 2017 | 575 | 0 | ||
| Gait stability in patients treated by fingolimod: A longitudinal pilot study on 9 patients with multiple sclerosis | Journal of the Neurological Sciences | | 2017 | 608 | 3 | ||
| Gait Profile Score in multiple sclerosis patients with low disability | Gait & Posture | | 2017 | 499 | 1 | ||
| Identification of a novel population of highly cytotoxic c-Met-expressing CD8(+) T lymphocytes | EMBO Reports | | 2017 | 529 | 4 | ||
| Upper limb movement analysis during gait in multiple sclerosis patients | Human movement science | | 2017 | 492 | 0 | ||
| [Paraneoplastic neurological syndromes: an update] | Revue médicale suisse | | 2016 | 461 | 0 | ||
| Sclérose en plaques de forme primaire progressive : un traitement se révèle enfin efficace | Revue médicale suisse | | 2016 | 524 | 8 | ||
| Myelin-reactive antibodies initiate T cell-mediated CNS autoimmune disease by opsonization of endogenous antigen | Acta neuropathologica | | 2016 | 485 | 0 | ||
| Multiple sclerosis relapse mimicking a transient ischemic attack | Multiple sclerosis and related disorders | | 2016 | 531 | 1 | ||
| Postural control is associated with cognition and fear of falling in patients with multiple sclerosis | Journal of neural transmission | | 2016 | 465 | 0 | ||
| Gait variability in multiple sclerosis: a better falls predictor than EDSS in patients with low disability | Journal of neural transmission | | 2016 | 593 | 1 | ||
| Stride time variability as a marker for higher level of gait control in multiple sclerosis: its association with fear of falling | Journal of neural transmission | | 2016 | 518 | 0 | ||
| Anti-ApoA-1 IgG serum levels predict worse post-stroke outcomes | European journal of clinical investigation | | 2016 | 560 | 6 | ||
| B cell-derived transforming growth factor-β1 expression limits the induction phase of autoimmune neuroinflammation | Scientific reports | | 2016 | 554 | 218 | ||
| Meningoencephalitis with microinfarcts in early neuroborreliosis | Neuroradiology | | 2016 | 498 | 1 | ||
| A phase IIa randomised clinical study of GNbAC1, a humanised monoclonal antibody against the envelope protein of multiple sclerosis-associated endogenous retrovirus in multiple sclerosis patients | Multiple sclerosis | | 2015 | 592 | 1 | ||
| Immunologic monitoring during a phase 2a trial of the GNbAC1 antibody in patients with MS | Neurology® neuroimmunology & neuroinflammation | | 2015 | 422 | 0 | ||
| Minimal supportive treatment in natalizumab-related PML in a MS patient | Journal of neurology, neurosurgery and psychiatry | | 2015 | 484 | 0 | ||
| A phase IIa randomized clinical study testing GNbAC1, a humanized monoclonal antibody against the envelope protein of multiple sclerosis associated endogenous retrovirus in multiple sclerosis patients - a twelve month follow-up | Journal of neuroimmunology | | 2015 | 500 | 1 | ||
| Hepatocyte growth factor: A regulator of inflammation and autoimmunity | Autoimmunity reviews | | 2015 | 477 | 0 | ||
| Hematologic modifications in natalizumab-treated multiple sclerosis patients: An 18-month longitudinal study | Neurology® neuroimmunology & neuroinflammation | | 2015 | 440 | 288 | ||
| Transient gadolinium leakage in natalizumab-treated multiple sclerosis | Journal of neurology, neurosurgery and psychiatry | | 2015 | 404 | 0 | ||
| Successful long-term ambulatory norepinephrine infusions in a patient with pure autonomic failure | Clinical autonomic research | | 2015 | 454 | 0 | ||
| Cannabinoïdes médicaux dans les douleurs chroniques : aspects pharmacologiques | Revue médicale suisse | | 2015 | 651 | 5 | ||
| Glatiramer acetate treatment negatively regulates type I interferon signaling | Neurology® neuroimmunology & neuroinflammation | | 2015 | 424 | 1 | ||
| Multifocal motor neuropathy with high titers of anti-MAG antibodies | Journal of the peripheral nervous system | | 2014 | 482 | 0 | ||
| Update on multiple sclerosis treatments | Schweizerische medizinische Wochenschrift | | 2014 | 444 | 1 | ||
| Fingolimod in a patient with Wolff-Parkinson-White syndrome | Multiple sclerosis | | 2014 | 400 | 0 | ||
| The neurotrophic hepatocyte growth factor induces protolerogenic human dendritic cells | Journal of neuroimmunology | | 2014 | 486 | 0 | ||
| Hepatocyte growth factor limits autoimmune neuroinflammation via glucocorticoid-induced leucine zipper expression in dendritic cells | The Journal of immunology | | 2014 | 649 | 3 | ||
| Dual-Task Assessment in Natalizumab-Treated Multiple Sclerosis Patients | European neurology | | 2014 | 644 | 4 | ||
| 18FDG-PET-CT: an imaging biomarker of high-risk carotid plaques. Correlation to symptoms and microembolic signals | Stroke | | 2014 | 636 | 3 | ||
| Walking while talking in patients with multiple sclerosis: the impact of specific cognitive loads | Neurophysiologie clinique | | 2014 | 585 | 3 | ||
| Traitement de la sclérose en plaques : nouveautés et complications | Revue médicale suisse | | 2013 | 414 | 0 | ||
| Cerebrospinal fluid interleukin-6 in central nervous system inflammatory diseases | PloS one | | 2013 | 671 | 408 | ||
| Neuropathies associées aux paraprotéinémies (gammapathies monoclonales) | Revue médicale suisse | | 2013 | 382 | 0 | ||
| Maladies auto-immunes neuromusculaires : diagnostic et prise en charge | Revue médicale suisse | | 2013 | 414 | 0 | ||
| The neurotrophic hepatocyte growth factor attenuates CD8+ cytotoxic T-lymphocyte activity | Journal of neuroinflammation | | 2013 | 585 | 329 | ||
| Neuroborréliose, méningo-encéphalite verno-estivale et neurosyphilis | Revue médicale suisse | | 2013 | 372 | 129 | ||
| Nogo-A downregulation improves insulin secretion in mice | Diabetes | | 2013 | 628 | 248 | ||
| [Head inflammation] | Revue médicale suisse | | 2013 | 364 | 0 | ||
| Adapted timed up and go: a rapid clinical test to assess gait and cognition in multiple sclerosis | European neurology | | 2012 | 682 | 0 | ||
| IgG glycan hydrolysis by EndoS inhibits experimental autoimmune encephalomyelitis | Journal of neuroinflammation | | 2012 | 653 | 309 | ||
| Interferon-β induces hepatocyte growth factor in monocytes of multiple sclerosis patients | PloS one | | 2012 | 633 | 247 | ||
| Hypereosinophilia in patients with multiple sclerosis treated with natalizumab | Neurology | | 2011 | 671 | 0 | ||
| Conformational epitopes of myelin oligodendrocyte glycoprotein are targets of potentially pathogenic antibody responses in multiple sclerosis | Journal of neuroinflammation | | 2011 | 593 | 293 | ||
| Antibody response in MOG35–55 induced EAE | Journal of neuroimmunology | | 2011 | 689 | 538 | ||
| Encephalitis associated with glutamic acid decarboxylase autoantibodies in a child: a treatable condition? | Archives of neurology | | 2011 | 595 | 0 | ||
| Glatiramer acetate in the treatment of multiple sclerosis: emerging concepts regarding its mechanism of action | CNS drugs | | 2011 | 529 | 0 | ||
| Highly reactive anti-myelin oligodendrocyte glycoprotein antibodies differentiate demyelinating diseases from viral encephalitis in children | Multiple sclerosis | | 2011 | 535 | 0 | ||
| Biomarqueurs en neuroimmunologie | Revue médicale suisse | | 2011 | 464 | 1 | ||
| Repetitive pertussis toxin promotes development of regulatory T cells and prevents central nervous system autoimmune disease | PloS one | | 2010 | 670 | 648 | ||
| VGKC antibody-associated encephalitis, microbleeds and progressive brain atrophy | Journal of neurology | | 2010 | 603 | 261 | ||
| Glatiramer acetate triggers PI3Kdelta/Akt and MEK/ERK pathways to induce IL-1 receptor antagonist in human monocytes | Proceedings of the National Academy of Sciences of the United States of America | | 2010 | 617 | 0 | ||
| Behaviorally spontaneous confabulation in limbic encephalitis: the roles of reality filtering and strategic monitoring | Journal of the International Neuropsychological Society | | 2010 | 635 | 0 | ||
| MHC class II-restricted antigen presentation by plasmacytoid dendritic cells inhibits T cell-mediated autoimmunity | The Journal of experimental medicine | | 2010 | 619 | 1 | ||
| Hepatocyte growth factor inhibits CNS autoimmunity by inducing tolerogenic dendritic cells and CD25+Foxp3+ regulatory T cells | Proceedings of the National Academy of Sciences of the United States of America | | 2010 | 658 | 0 | ||
| Glatiramer acetate increases IL-1 receptor antagonist but decreases T cell-induced IL-1beta in human monocytes and multiple sclerosis | Proceedings of the National Academy of Sciences of the United States of America | | 2009 | 582 | 0 | ||
| Peripheral autoimmune neuropathy assessed using corneal in vivo confocal microscopy | Archives of neurology | | 2009 | 606 | 0 | ||
| Anomalous brain dominance and the immune system: do left-handers have specific immunological patterns? | Brain and cognition | | 2009 | 586 | 0 | ||
| Increasing the diagnostic value of evoked potentials in multiple sclerosis by quantitative topographic analysis of multichannel recordings | Journal of clinical neurophysiology | | 2009 | 590 | 2 | ||
| Autoanticorps en neurologie : implications cliniques | Revue médicale suisse | | 2009 | 499 | 0 | ||
| Syndrome of transient headache and neurological deficits with CSF lymphocytosis (HaNDL) associated with recent human herpesvirus-6 infection | Cephalalgia | | 2009 | 628 | 1 | ||
| Interferon-beta induces brain-derived neurotrophic factor in peripheral blood mononuclear cells of multiple sclerosis patients | Journal of neuroimmunology | | 2008 | 571 | 0 | ||
| Glatiramer acetate treatment does not modify the clinical course of (NZB x BXSB)F1 lupus murine model | International immunology | | 2008 | 583 | 1 | ||
| Human herpesvirus-6 variant A encephalomyelitis | Neurology | | 2008 | 611 | 0 | ||
| Autoantibodies in inflammatory demyelinating diseases of the central nervous system | Schweizerische medizinische Wochenschrift | | 2008 | 549 | 4 | ||
| TNF-alpha and psychologically stressful events in healthy subjects: potential relevance for multiple sclerosis relapse | Behavioral neuroscience | | 2002 | 429 | 0 | ||
| Encéphalopathie complexe, transitoire et récidivante après résection étendue de l'intestin grêle. Responsabilité du D-Lactate | Revue neurologique | 2001 | 528 | 0 | |||
| Lower limb corticobasal degeneration | European neurology | | 2000 | 527 | 0 |
